After gene set enrichment analysis, we determined that the IFNγ signaling pathway was up-regulated in CMT167 cancer cells relative to LLC cells in vivo (Fig 1A and Table S1), suggesting that these cells have a differential response to IFNγ. This evidence concerns the gene IFNG and cancer.